The human UDP-glucuronosyltransferases: structural aspects and drug glucuronidation.
about
Human UDP-glucuronosyltransferase UGT2A2: cDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A3Bioavailability of dietary polyphenols and gut microbiota metabolism: antimicrobial propertiesUGT genomic diversity: beyond gene duplication.Inhibitory effects of commonly used herbal extracts on UDP-glucuronosyltransferase 1A4, 1A6, and 1A9 enzyme activities.The first aspartic acid of the DQxD motif for human UDP-glucuronosyltransferase 1A10 interacts with UDP-glucuronic acid during catalysis.Pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 polymorphisms: are we there yet?High-throughput screening technologies for drug glucuronidation profiling.Comprehensive evaluation of a novel nuclear factor-kappaB inhibitor, quinoclamine, by transcriptomic analysisN-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases.Substrate selectivity of human intestinal UDP-glucuronosyltransferases (UGTs): in silico and in vitro insights.In Vitro Inhibition of Human UDP-Glucuronosyl-Transferase (UGT) Isoforms by Astaxanthin, β-Cryptoxanthin, Canthaxanthin, Lutein, and Zeaxanthin: Prediction of in Vivo Dietary Supplement-Drug Interactions.Inhibitory effects of commonly used herbal extracts on UGT1A1 enzyme activity.S-Glucuronidation of 7-mercapto-4-methylcoumarin by human UDP glycosyltransferases in genetically engineered fission yeast cells.
P2860
Q24310887-233F7256-D7F6-40BB-AE0D-AF481A504EDEQ27001250-CC5D7D0F-75E7-4D6C-8C52-12F4CE4A2762Q35009521-CAD71D27-9095-40D9-8F6D-498C78F7A826Q35187885-BA91462C-CFB9-48C6-8323-8F3F2B5AAAFDQ36509173-5FE671C2-95DE-4D0D-B8B8-B04F7F61B1F0Q37173199-AF9C3741-5A0E-411E-A0DE-FBD0CE2DF373Q37222804-494F1EBC-0ED0-4079-847E-228860CF7BD3Q37290391-F639A13C-C76E-4C5B-B30A-A4326A39D04DQ37857239-3937626A-92C9-4C73-A66C-BEF8EE042A6EQ38086603-BD8877D9-7D51-46F2-AFE7-EA1856BDB815Q39486132-A0C3FEAE-4B6A-46FE-B56E-3AE91C1396F6Q42953779-C39729DB-7DC1-4E16-A913-C47D58C6E1EFQ46710872-C875D9B1-9DC0-4762-9D3D-931172D28B79
P2860
The human UDP-glucuronosyltransferases: structural aspects and drug glucuronidation.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The human UDP-glucuronosyltransferases: structural aspects and drug glucuronidation.
@ast
The human UDP-glucuronosyltransferases: structural aspects and drug glucuronidation.
@en
type
label
The human UDP-glucuronosyltransferases: structural aspects and drug glucuronidation.
@ast
The human UDP-glucuronosyltransferases: structural aspects and drug glucuronidation.
@en
prefLabel
The human UDP-glucuronosyltransferases: structural aspects and drug glucuronidation.
@ast
The human UDP-glucuronosyltransferases: structural aspects and drug glucuronidation.
@en
P2093
P2860
P356
P1476
The human UDP-glucuronosyltransferases: structural aspects and drug glucuronidation.
@en
P2093
Lydia Barré
Mohamed Ouzzine
Patrick Netter
Sylvie Fournel-Gigleux
P2860
P304
P356
10.1081/DMR-120026397
P407
P577
2003-11-01T00:00:00Z